Trial Outcomes & Findings for Trial of Low Residue Diet Versus Clear Liquids Following Elective Colorectal Surgery (NCT NCT03260426)

NCT ID: NCT03260426

Last Updated: 2020-01-31

Results Overview

Patient tolerability, as evidenced by development of vomiting on postoperative day two.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

100 participants

Primary outcome timeframe

POD 2

Results posted on

2020-01-31

Participant Flow

Participant milestones

Participant milestones
Measure
Clear Liquid Diet
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Overall Study
STARTED
50
50
Overall Study
COMPLETED
50
50
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Clear Liquid Diet
n=50 Participants
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 Participants
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Total
n=100 Participants
Total of all reporting groups
Age, Continuous
47.5 years
STANDARD_DEVIATION 50 • n=5 Participants
45.5 years
STANDARD_DEVIATION 50 • n=7 Participants
46.5 years
STANDARD_DEVIATION 100 • n=5 Participants
Sex: Female, Male
Female
28 Participants
n=5 Participants
28 Participants
n=7 Participants
56 Participants
n=5 Participants
Sex: Female, Male
Male
22 Participants
n=5 Participants
22 Participants
n=7 Participants
44 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
50 Participants
n=5 Participants
50 Participants
n=7 Participants
100 Participants
n=5 Participants
Body Mass Index
23.6 kg/m^2
STANDARD_DEVIATION 4.3 • n=5 Participants
22.7 kg/m^2
STANDARD_DEVIATION 4.9 • n=7 Participants
23.1 kg/m^2
STANDARD_DEVIATION 4.1 • n=5 Participants
Prior abdominal surgery
21 Participants
n=5 Participants
20 Participants
n=7 Participants
41 Participants
n=5 Participants
Site of surgery
Small bowel
9 Participants
n=5 Participants
12 Participants
n=7 Participants
21 Participants
n=5 Participants
Site of surgery
Right colon
13 Participants
n=5 Participants
12 Participants
n=7 Participants
25 Participants
n=5 Participants
Site of surgery
Subtotal/left
14 Participants
n=5 Participants
9 Participants
n=7 Participants
23 Participants
n=5 Participants
Site of surgery
pelvis
14 Participants
n=5 Participants
17 Participants
n=7 Participants
31 Participants
n=5 Participants
Diagnosis
IBD
39 Participants
n=5 Participants
37 Participants
n=7 Participants
76 Participants
n=5 Participants
Diagnosis
Cancer
8 Participants
n=5 Participants
6 Participants
n=7 Participants
14 Participants
n=5 Participants
Diagnosis
Other
3 Participants
n=5 Participants
7 Participants
n=7 Participants
10 Participants
n=5 Participants
Ostomy Use
Ileostomy
24 Participants
n=5 Participants • Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.
22 Participants
n=7 Participants • Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.
46 Participants
n=5 Participants • Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.
Ostomy Use
Colostomy
2 Participants
n=5 Participants • Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.
1 Participants
n=7 Participants • Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.
3 Participants
n=5 Participants • Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.
Ostomy Use
No ostomy
24 Participants
n=5 Participants • Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.
27 Participants
n=7 Participants • Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.
51 Participants
n=5 Participants • Out of the 100 patients total of 49 patients received an ostomy. at the time of surgery. 46 patient received and ileostomy and 3 patients received a colostomy.
Anastomosis
Anastomosis formed
35 Participants
n=5 Participants
36 Participants
n=7 Participants
71 Participants
n=5 Participants
Anastomosis
No Anastomosis
15 Participants
n=5 Participants
14 Participants
n=7 Participants
29 Participants
n=5 Participants

PRIMARY outcome

Timeframe: POD 2

Population: All participants undergoing surgery

Patient tolerability, as evidenced by development of vomiting on postoperative day two.

Outcome measures

Outcome measures
Measure
Clear Liquid Diet
n=50 Participants
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 Participants
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Number of Participants Who Experienced Emesis on Post Operative Day 2
9 Participants
9 Participants

SECONDARY outcome

Timeframe: POD 0

Population: All participants undergoing surgery

Tolerability of regular diet will be determined by the patients ability to eat more than 50% of a solid meal on post operative day zero.

Outcome measures

Outcome measures
Measure
Clear Liquid Diet
n=50 Participants
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 Participants
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Number of Participants Able to Tolerate a Regular Diet as Compared to a Clear Liquid Diet on Post Operative Day 0 (POD 0).
46 Participants
34 Participants

SECONDARY outcome

Timeframe: 30 days

Population: All participants undergoing surgery

If antiemetics were used in

Outcome measures

Outcome measures
Measure
Clear Liquid Diet
n=50 Participants
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 Participants
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Antiemetic Usage
37 Participants
30 Participants

SECONDARY outcome

Timeframe: 30 days

Length of postoperative stay

Outcome measures

Outcome measures
Measure
Clear Liquid Diet
n=50 Participants
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 Participants
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Hospital Stay
3 days
Standard Error 3.5
2.5 days
Standard Error 4.0

SECONDARY outcome

Timeframe: 30 days

Population: All participants undergoing surgery

Development of post-operative ileus

Outcome measures

Outcome measures
Measure
Clear Liquid Diet
n=50 Participants
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 Participants
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Post-operative Ileus
11 Participants
11 Participants

SECONDARY outcome

Timeframe: POD 1 and POD 2 and Discharge

Population: All participants undergoing surgery

Instrument title: Quality of Life Assessment Visual Analogue scale.Higher scores mean a worse outcome. Pain score evaluated POD 1 and POD 2 and Discharge by using a self reported quality of life measure at regular intervals using a visual analog scale (0-10). A higher score means worse outcome and lower score means better outcome.

Outcome measures

Outcome measures
Measure
Clear Liquid Diet
n=50 Participants
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 Participants
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Pain Score
POD 1
4 score on a scale
Interval 0.0 to 10.0
4 score on a scale
Interval 0.0 to 10.0
Pain Score
POD 2
3 score on a scale
Interval 0.0 to 10.0
4 score on a scale
Interval 0.0 to 10.0
Pain Score
Discharge
2 score on a scale
Interval 0.0 to 10.0
3 score on a scale
Interval 0.0 to 10.0

SECONDARY outcome

Timeframe: POD 1 and POD 2 and Discharge

Population: All participants undergoing surgery.

Instrument title: Quality of Life Assessment Visual Analogue scale.Higher scores mean a worse outcome. Nausea Score on POD 1 and POD 2 and Discharge by using a self reported quality of life measure at regular intervals using a visual analog scale (0-10). A higher score means worse outcome and lower score means better outcome.

Outcome measures

Outcome measures
Measure
Clear Liquid Diet
n=50 Participants
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 Participants
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Nausea Score
Discharge
1 score on a scale
Interval 0.0 to 10.0
1 score on a scale
Interval 0.0 to 10.0
Nausea Score
POD 1
1 score on a scale
Interval 0.0 to 10.0
1 score on a scale
Interval 0.0 to 10.0
Nausea Score
POD 2
1 score on a scale
Interval 0.0 to 10.0
1 score on a scale
Interval 0.0 to 10.0

SECONDARY outcome

Timeframe: POD 1 and POD 2 and Discharge

Population: All participants undergoing surgery.

Instrument title: Quality of Life Assessment Visual Analogue scale.Higher scores mean a worse outcome. Bloating Score on POD 1 and POD 2 and Discharge by using a self reported quality of life measure at regular intervals using a visual analog scale (0-10). A higher score means worse outcome and lower score means better outcome.

Outcome measures

Outcome measures
Measure
Clear Liquid Diet
n=50 Participants
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 Participants
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Bloating Score
POD 1
3 score on a scale
Interval 0.0 to 10.0
2 score on a scale
Interval 0.0 to 10.0
Bloating Score
POD 2
2 score on a scale
Interval 0.0 to 10.0
2 score on a scale
Interval 0.0 to 10.0
Bloating Score
POD 3
2 score on a scale
Interval 0.0 to 10.0
2 score on a scale
Interval 0.0 to 10.0

Adverse Events

Clear Liquid Diet

Serious events: 11 serious events
Other events: 0 other events
Deaths: 0 deaths

Regular Solid Diet

Serious events: 11 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Clear Liquid Diet
n=50 participants at risk
Clear liquids on postoperative day zero and intestinal rate measured by Abstats Clear Liquids: Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician. Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Regular Solid Diet
n=50 participants at risk
Regular diet from postoperative day zero and intestinal rate measured by Abstats Regular Solid: Regular diet from postoperative day zero immediately upon return to floor and onwards Abstats: Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery
Gastrointestinal disorders
Post-operative Ileus
22.0%
11/50 • 30 days
22.0%
11/50 • 30 days

Other adverse events

Adverse event data not reported

Additional Information

Phillip Fleshner, MD

Cedars Sinai Medical Center

Phone: 310-289-9224

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place